Form 4 for NMRA Neumora Therapeutics, Inc.
Accepted 2024-06-28 00:00:00 ET · period of report 2024-04-17 · accession 0001610717-24-000380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-28 | 2024-04-17 | NMRA | Pinto Joshua | CFO | G - Gift | $0.00 | -239.0K | 239.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-17 | G | D | 238,965 | $0.00 | 238,965 | I See footnote | — | — | (F2) Shares held by Maple DE Holdings LLC, which is the entity defined above as "Family LLC". |